Global RNAi for Therapeutic Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2021

According to Custom Market Inights analysis, The global rnai for therapeutic consumption market is expected to register a healthy CAGR during the period from 2016 to 2025. This report studies the rnai for therapeutic consumption status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the rnai for therapeutic consumption by product type and applications/end industries.

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Scope of the Report:
This report focuses on the RNAi for Therapeutic Consumption in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle and Africa

Market Segment by Type, covers
siRNA
miRNA
shRNA

Market Segment by Applications, can be divided into
Cancer
Cardiovascular
HBV
Other

There are 10 Chapters to deeply display the global RNAi for Therapeutic Consumption market.
Chanter 1, to analyze the top manufacturers of RNAi for Therapeutic Consumption, with sales, revenue, and price of RNAi for Therapeutic Consumption, in 2015 and 2016;

Chapter 2, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 3, to show the global market by regions, with sales, revenue and market share of RNAi for Therapeutic Consumption, for each region, from 2011 to 2016;

Chapter 4, 5, 6 and 7, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016.

Chapter 10, RNAi for Therapeutic Consumption market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021.

Table of Contents

Global RNAi for Therapeutic Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Manufacturers Profiles
1.1 Alnylam Pharmaceuticals
1.1.1 Business Overview
1.1.2 RNAi for Therapeutic Consumption Type and Applications
1.1.2.1 Type 1
1.1.2.2 Type 2
1.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.2 Arrowhead
1.2.1 Business Overview
1.2.2 RNAi for Therapeutic Consumption Type and Applications
1.2.2.1 Type 1
1.2.2.2 Type 2
1.2.2 Arrowhead RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.3 Dicerna Pharmaceuticals
1.3.1 Business Overview
1.3.2 RNAi for Therapeutic Consumption Type and Applications
1.3.2.1 Type 1
1.3.2.2 Type 2
1.3.2 Dicerna Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.4 Mirna Therapeutics
1.4.1 Business Overview
1.4.2 RNAi for Therapeutic Consumption Type and Applications
1.4.2.1 Type 1
1.4.2.2 Type 2
1.4.2 Mirna Therapeutics RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.5 Quark Pharmaceuticals
1.5.1 Business Overview
1.5.2 RNAi for Therapeutic Consumption Type and Applications
1.5.2.1 Type 1
1.5.2.2 Type 2
1.5.2 Quark Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.6 RXi Pharmaceuticals
1.6.1 Business Overview
1.6.2 RNAi for Therapeutic Consumption Type and Applications
1.6.2.1 Type 1
1.6.2.2 Type 2
1.6.2 RXi Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.7 miRagen Therapeutics
1.7.1 Business Overview
1.7.2 RNAi for Therapeutic Consumption Type and Applications
1.7.2.1 Type 1
1.7.2.2 Type 2
1.7.2 miRagen Therapeutics RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.8 Gradalis
1.8.1 Business Overview
1.8.2 RNAi for Therapeutic Consumption Type and Applications
1.8.2.1 Type 1
1.8.2.2 Type 2
1.8.2 Gradalis RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
1.9 Sirnaomics
1.9.1 Business Overview
1.9.2 RNAi for Therapeutic Consumption Type and Applications
1.9.2.1 Type 1
1.9.2.2 Type 2
1.9.2 Sirnaomics RNAi for Therapeutic Consumption Sales, Price, Revenue and Market Share
2 Global RNAi for Therapeutic Consumption Market Competition, by Manufacturer
2.1 Global RNAi for Therapeutic Consumption Sales and Market Share by Manufacturer
2.2 Global RNAi for Therapeutic Consumption Revenue and Market Share by Manufacturer
3 Global RNAi for Therapeutic Consumption Market Analysis by Regions
3.1.1 Global RNAi for Therapeutic Consumption Sales by Regions (2011-2016)
3.1.2 Global RNAi for Therapeutic Consumption Revenue by Regions (2011-2016)
3.2 North America (USA, Canada and Mexico) RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
3.3 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
3.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
3.5 Latin America, Middle and Africa RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
3.6 RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
4 North America (USA, Canada and Mexico) RNAi for Therapeutic Consumption by Countries
4.1 North America (USA, Canada and Mexico) RNAi for Therapeutic Consumption Sales, Revenue and Market Share by Countries
4.1.1 North America (USA, Canada and Mexico) RNAi for Therapeutic Consumption Sales by Countries (2011-2016)
4.1.2 North America (USA, Canada and Mexico) RNAi for Therapeutic Consumption Revenue by Countries (2011-2016)
4.2 USA RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
4.3 Canada RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
4.4 Mexico RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
5 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Consumption by Countries
5.1 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Consumption Sales, Revenue and Market Share by Countries
5.1.1 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Consumption Sales by Countries (2011-2016)
5.1.2 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Consumption Revenue by Countries (2011-2016)
5.2 Germany RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
5.3 UK RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
5.4 France RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
5.5 Russia RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
5.6 Italy RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Consumption by Countries
6.1 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Consumption Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Consumption Sales by Countries (2011-2016)
6.1.2 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Consumption Revenue by Countries (2011-2016)
6.2 China RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
6.3 Japan RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
6.4 Korea RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
6.5 India RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
6.6 Southeast Asia RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
7 Latin America, RNAi for Therapeutic Consumption by Countries
7.1 Latin America, RNAi for Therapeutic Consumption Sales, Revenue and Market Share by Countries
7.1.1 Latin America, RNAi for Therapeutic Consumption Sales by Countries (2011-2016)
7.1.2 Latin America, RNAi for Therapeutic Consumption Revenue by Countries (2011-2016)
7.2 Brazil RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
7.3 Saudi Arabia RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
7.4 Egypt RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
7.5 Nigeria RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
7.6 South Africa RNAi for Therapeutic Consumption Sales and Growth (2011-2016)
8 RNAi for Therapeutic Consumption Market Segment by Type
8.1 Global RNAi for Therapeutic Consumption Sales, Revenue and Market Share by Type (2011-2016)
8.1.2 Global RNAi for Therapeutic Consumption Revenue and Market Share by Type (2011-2016)
8.1.1 Global RNAi for Therapeutic Consumption Sales and Market Share by Type (2011-2016)
8.2 siRNA
8.2.1 Global siRNA Sales Growth (2011-2016)
8.2.2 Global siRNA Price (2011-2016)
8.3 miRNA
8.3.1 Global miRNA Sales Growth (2011-2016)
8.3.2 Global miRNA Price (2011-2016)
8.4 shRNA
8.4.1 Global shRNA Sales Growth (2011-2016)
8.4.2 Global shRNA Price (2011-2016)
8.5
8.5.1 Global Sales Growth (2011-2016)
8.5.2 Global Price (2011-2016)
9 RNAi for Therapeutic Consumption Market Segment by Application
9.1 Global RNAi for Therapeutic Consumption Sales Market Share by Application (2011-2016)
9.2 Cancer
9.2.1 Cancer Overview
9.2.2 Cancer Sales Growth (2011-2016)
9.3 Cardiovascular
9.3.1 Cardiovascular Overview
9.3.2 Cardiovascular Sales Growth (2011-2016)
9.4 HBV
9.4.1 HBV Overview
9.4.2 HBV Sales Growth (2011-2016)
9.5 Other
9.5.1 Other Overview
9.5.2 Other Sales Growth (2011-2016)
10 RNAi for Therapeutic Consumption Market Forecast (2016-2021)
10.1 Global RNAi for Therapeutic Consumption Sales, Revenue and Growth Rate (2016-2021)
10.2 RNAi for Therapeutic Consumption Market Forecast by Regions (2016-2021)
10.3 RNAi for Therapeutic Consumption Market Forecast by Type (2016-2021)
10.4 RNAi for Therapeutic Consumption Market Forecast by Application (2016-2021)
10.5 Market Dynamics
10.5.1 Market Opportunities
10.5.2 Market Constraints
10.5.3 Driving Force
11 Appendix
11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Jacob Thomass